Current promising treatment strategy for glioblastoma multiform: A review
Glioblastoma multiform (GBM) is a heterogeneous group of primary neoplasm resistant to conventional therapies. Due to their infiltrative nature it not fully isolated by aggressive surgery, radiation and chemotherapy showing poor prognosis in glioma patients. Unfortunately, diagnosed patients die wi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-07-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://www.oncologyreviews.org/index.php/or/article/view/417 |